Herantis Pharma (OHEL:HRTIS) Cash Flow for Lease Financing: €0.00 Mil (TTM As of Dec. 2025)


OHEL:HRTIS Herantis Pharma PLC OHEL:HRTIS
27 GF Score
Price €1.86
! 3 Warning Signs
View Full Analysis

What is Herantis Pharma Cash Flow for Lease Financing?

Herantis Pharma OHEL:HRTIS +1.09% 27 Cash Flow for Lease Financing is €0.00 Mil as of Dec. 2025. GuruFocus rates OHEL:HRTIS with a GF Score™ of 27/100. The stock has 3 warning signs investors should review.

Herantis Pharma's Cash Flow for Lease Financing for the six months ended in Dec. 2025 was €0.00 Mil. Herantis Pharma's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2025 ), Herantis Pharma's Cash Flow for Lease Financing remained the same in Dec. 2025 (€0.00 Mil).

Herantis Pharma Cash Flow for Lease Financing Historical Data

* Premium members only.

The historical data trend for Herantis Pharma's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Herantis Pharma Cash Flow for Lease Financing Chart

Herantis Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Herantis Pharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OHEL:HRTIS
27GF Score
Herantis Pharma PLC OHEL:HRTIS
Cash Flow for Lease Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Herantis Pharma Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Lease Financing of €0.00 Mil mean?
Herantis Pharma (OHEL:HRTIS) has a Cash Flow for Lease Financing of €0.00 Mil as of Dec. 2025. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Herantis Pharma and its competitors.
Is Herantis Pharma's Cash Flow for Lease Financing too high?
Herantis Pharma's current Cash Flow for Lease Financing is €0.00 Mil. Overall, Herantis Pharma has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Herantis Pharma's Cash Flow for Lease Financing compare to VRTX and REGN?
Herantis Pharma's Cash Flow for Lease Financing of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Lease Financing for a Biotechnology company?
A good Cash Flow for Lease Financing depends on the Biotechnology industry context. However, Cash Flow for Lease Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Lease Financing mean?
A high Cash Flow for Lease Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Herantis Pharma and its competitors. Herantis Pharma's current Cash Flow for Lease Financing is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Herantis Pharma stock overvalued right now?
Herantis Pharma (OHEL:HRTIS) has a current Cash Flow for Lease Financing of €0.00 Mil. The current Cash Flow for Lease Financing is €0.00 Mil. Herantis Pharma's overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Lease Financing calculated?
Cash Flow for Lease Financing is calculated from a company's financial statements. For Herantis Pharma (OHEL:HRTIS), the current Cash Flow for Lease Financing is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Herantis Pharma Business Description

Address Bertel Jungin Aukio 1, Espoo, FIN, 02600
Herantis Pharma PLC is a biotech company developing disease-modifying therapies for Parkinsons disease. The company's current development program focuses solely on HER-096, which is a peptidomimetic molecule designed to retain the biological activity of the neuroprotective CDNF protein.
27GF Score

Get the complete analysis for OHEL:HRTIS

Cash Flow for Lease Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.86
Price